Groups | Average body weight gain (g) | Relative body weight gain (%) | Mean lesion scores | Average OPG (× 105) | Oocyst decrease ratio (%) | ACI |
---|---|---|---|---|---|---|
rEmROM2 | 50.25 ± 6.33b | 88.30b | 1.67 ± 0.65b | 0.51 ± 0.68b | 73.33b | 170.60 |
pET-32a control | 29.46 ± 11.25c | 51.77c | 2.66 ± 0.93c | 2.15 ± 0.97c | 4.44c | 85.17 |
Challenged control | 27.21 ± 8.52c | 47.81c | 2.84 ± 0.88c | 2.25 ± 0.94c | 0c | 79.41 |
Unchallenged control | 56.91 ± 10.24a | 100a | 0 ± 0a | 0 ± 0a | 100a | 200 |
pVAX1-EmROM2 | 63.84 ± 8.80b | 80.54b | 1.68 ± 0.99b | 0.57 ± 0.31b | 79.72b | 162.74 |
pVAX1 control | 38.19 ± 15.39c | 48.15c | 2.75 ± 0.62c | 2.80 ± 0.16c | 0.36c | 80.65 |
Challenged control | 39.28 ± 9.72c | 49.53c | 2.83 ± 0.72c | 2.81 ± 0.13c | 0c | 81.23 |
Unchallenged control | 79.32 ± 9.59a | 100a | 0 ± 0a | 0 ± 0a | 100a | 200 |